Daniel D. Truong

1.1k total citations
20 papers, 761 citations indexed

About

Daniel D. Truong is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Daniel D. Truong has authored 20 papers receiving a total of 761 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Molecular Biology. Recurrent topics in Daniel D. Truong's work include Neurological disorders and treatments (9 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Neuroscience and Neuropharmacology Research (4 papers). Daniel D. Truong is often cited by papers focused on Neurological disorders and treatments (9 papers), Botulinum Toxin and Related Neurological Disorders (7 papers) and Neuroscience and Neuropharmacology Research (4 papers). Daniel D. Truong collaborates with scholars based in United States, Netherlands and Thailand. Daniel D. Truong's co-authors include Robert A. Hauser, Jean Hubble, Lawrence Elmer, Mark Stacy, Bonnie Hersh, Kelly E. Lyons, Fabrizio Stocchi, Nancy L. Earl, Stewart A. Factor and Rajesh Pahwa and has published in prestigious journals such as Neurology, Brain Research and Clinical Cancer Research.

In The Last Decade

Daniel D. Truong

19 papers receiving 745 citations

Peers

Countries citing papers authored by Daniel D. Truong

Since Specialization

Citations

This map shows the geographic impact of Daniel D. Truong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel D. Truong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel D. Truong more than expected).

Fields of papers citing papers by Daniel D. Truong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel D. Truong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel D. Truong. The network helps show where Daniel D. Truong may publish in the future.

Co-authorship network of co-authors of Daniel D. Truong

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel D. Truong. A scholar is included among the top collaborators of Daniel D. Truong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel D. Truong. Daniel D. Truong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	IAPRD new consensus classification of myoclonus 2024 ·Parkinsonism & Related Disorders ·Anna Latorre, Sterre van der Veen, (unknown), Daniel D. Truong, Roberto Erro, Steven J. Frucht, Christos Ganos, Mark Hallett, Belén Pérez‐Dueñas, Malco Rossi, Emmanuel Roze, Marie Vidailhet, (unknown), John N. Caviness	3
2	Development and validation of the Vietnamese smell identification test 2023 ·Parkinsonism & Related Disorders ·(unknown), (unknown), Truc Thanh Thai, Hien Thi Thu Le, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Thành Vinh Nguyễn, Thanh Van Nguyen, (unknown), Daniel D. Truong	2
3	Patient selection and injection techniques for botulinum neurotoxin in oromandibular dystonia 2022 ·Clinical Parkinsonism & Related Disorders ·Roongroj Bhidayasiri, (unknown), Daniel D. Truong	3
4	Outcomes of week-24 completers and subjects who had follow-up beyond week 24 after a single treatment of daxibotulinumtoxinA for injection (RT002): Results of a phase 2, open-label (Level II), dose-escalating study in isolated cervical dystonia 2018 ·Toxicon ·Atul T. Patel, Cynthia Comella, Joseph Jankovic, Daniel D. Truong, Allison Brashear, Marian L. Evatt, Daniel Snyder, Roman G. Rubio	1
5	Safety and Efficacy Study of ADS-5102 (Amantadine HCl) Extended Release Capsules in Levodopa-Induced Dyskinesia (EASED Study) (P4.053) 2014 ·Neurology ·Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser, Kapil D. Sethi, Stuart Isaacson, Daniel D. Truong, Lynn K. Struck, Mary Jean Stempien, (unknown), (unknown)	3
6	Prognostic Significance of Plasma Osteopontin in Patients with Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Treated on TROG 02.02 Phase III Trial 2011 ·Clinical Cancer Research ·Annette M. Lim, Danny Rischin, Richard Fisher, Hongbin Cao, Kathleen Kwok, Daniel D. Truong, Grant A. McArthur, Richard J. Young, Amato J. Giaccia, Lester Peters, Quynh‐Thu Le	36
7	Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6. 2010 ·PubMed ·Jianfeng Xiao, (unknown), Robert W. Bastian, Joel S. Perlmutter, Brad A. Racette, (unknown), Morvarid Karimi, Randal C. Paniello, Andrew Blitzer, Sat Dev Batish, Zbigniew K. Wszołek, Ryan J. Uitti, Jay A. van Gerpen, Peter Hedera, (unknown), Daniel Tarsy, Daniel D. Truong, Karen Frei, Ronald F. Pfeiffer, Suzhen Gong, Mark S. LeDoux	5
8	Recognition and management of Parkinson’s disease during the premotor (prodromal) phase 2009 ·Expert Review of Neurotherapeutics ·Daniel D. Truong, Erik Ch. Wolters	11
9	Case Studies in the Advancement of Parkinson's Disease 2008 ·CNS Spectrums ·Karen Frei, Daniel D. Truong, Erik Ch. Wolters	6
10	“Dystonic” body perception in childhood dystonia 2007 ·Clinical Neurology and Neurosurgery ·Roongroj Bhidayasiri, Daniel D. Truong	0
11	Ropinirole 24-hour prolonged release 2007 ·Neurology ·Rajesh Pahwa, Mark Stacy, Stewart A. Factor, Kelly E. Lyons, Fabrizio Stocchi, Bonnie Hersh, Lawrence Elmer, Daniel D. Truong, Nancy L. Earl	231
12	Molecular defects of the dystonia-causing torsinA mutation 2006 ·Neuroreport ·(unknown), Karen Frei, (unknown), Daniel D. Truong	22
13	Randomized trial of the adenosine A _2A receptor antagonist istradefylline in advanced PD 2003 ·Neurology ·Robert A. Hauser, Jean Hubble, Daniel D. Truong, (unknown)	237
14	Antimyoclonic and neuroprotective effects of lamotrigine in an animal model of cardiac arrest 1999 ·Restorative Neurology and Neuroscience ·Anumantha G. Kanthasamy, (unknown), (unknown), (unknown), Daniel D. Truong	5
15	Effect of Riluzole on the Neurological and Neuropathological Changes in an Animal Model of Cardiac Arrest-Induced Movement Disorder 1999 ·Journal of Pharmacology and Experimental Therapeutics ·Anumantha G. Kanthasamy, (unknown), (unknown), Daniel D. Truong	21
16	Evidence for the Involvement of Histamine in the Antidystonic Effects of Diphenhydramine 1995 ·Experimental Neurology ·(unknown), Mark R. Stone, (unknown), Daniel D. Truong, Rae R. Matsumoto	14
17	Novel rat cardiac arrest model of posthypoxic myoclonus 1994 ·Movement Disorders ·Daniel D. Truong, Rae R. Matsumoto, Philip H. Schwartz, (unknown), Claude G. Wasterlain	31
18	Treatment of oromandibular dystonia with botulinum toxin 1991 ·The Laryngoscope ·Neal Hermanowicz, Daniel D. Truong	39
19	Brachial plexopathy after botulinum toxin injections 1990 ·Neurology ·Robert Glanzman, Douglas J. Gelb, Ivo Drury, Mark B. Bromberg, Daniel D. Truong	29
20	Non-chromaffin tissue plus nerve growth factor reduces experimental parkinsonism in aged rats 1988 ·Brain Research ·Gianni Pezzoli, Stanley Fahn, Andrew J. Dwork, Daniel D. Truong, Justo Garcı́a de Yébenes, Vernice Jackson‐Lewis, Joseph Herbert, Jean Lud Cadet	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact